{"metadata": {"source": "erowid", "title": "Erowid LSD (Acid) Vault : FAQ", "description": "Frequently Asked Questions about LSD", "language": "No language found.", "url": "https://www.erowid.org/chemicals/lsd/lsd_faq.shtml", "drug": "LSD", "cid": 5761, "substance": "lsd", "category": "CHEMICALS", "erowid_column": "FAQ", "char_count": 70642, "word_count": 10952, "doc_id": "doc_156", "num_chunks": 103, "chunk_id": "156::chunk_54", "document_index": 156, "latency_s": 1.0655930999928387, "prompt_toks": 16446, "completion_toks": 71, "relevance_score": 4.840077e-08}, "content": "Drug: LSD | cid: 5761\nSource: erowid | Source description: Frequently Asked Questions about LSD\nErowid name: lsd\nCategory: CHEMICALS\nField: FAQ\n\n                    Text: \n                    Here are two more troublesome examples: For about a week I couldn't walk through the lobby of A-entry at the dorm without getting really scared, because of the goblin I saw there when I was tripping. (Pope 1971, p. 93) A man in his late twenties came to the admitting office in a state of panic. Althought he had not taken any drug in approximately 2 months he was beginning to re-experience some of the illusory phenomena, perceptual distortions, and the feeling of union with the things areound him that had previously occurred only under the influence of LSD. In addition, his wife had told him that he was beginning to \"talk crazy,\" and he had become frightened ... He was concerned lest LSD have some permanent effect on him. He wished reassurance so that he could take it again. His symptoms have subsided but tend to reappear in anxiety-provoking situations. (Frosch et al. 1965, p. 1237) Flashbacks are most likely to occur under emotional stress or at a time of altered ego functioning;\n\n\n                    Context: \n                    This segment discusses the phenomenon of LSD flashbacks and their psychological impact, providing specific case examples of individuals experiencing re-emerging visual distortions and perceptual phenomena months after use. It highlights that flashbacks often occur under stress or altered ego states, emphasizing their relevance to understanding LSD's long-term psychological effects within the broader context of drug risks and adverse reactions.\n                "}
{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_24", "document_index": 84, "latency_s": 1.3235749000014039, "prompt_toks": 6478, "completion_toks": 106, "relevance_score": 4.546832e-08}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    \"Cannabis study reveals how CBD offsets the psychiatric side-effects of THC\". ScienceDaily (Press release). September 30, 2019.\n\n↑ https://www.scielo.br/j/bjmbr/a/5sGSHxqFkYHxCYhRZh6fWKH/?format=pdf&lang=en. Missing or empty |title= (help)\n\n↑ Czégény, Z; Nagy, G; Babinszki, B; Bajtel, Á; Sebestyén, Z; Kiss, T; Csupor-Löffler, B; Tóth, B; Csupor, D (26 April 2021). \"CBD, a precursor of THC in e-cigarettes\". Scientific reports. 11 (1): 8951. doi:10.1038/s41598-021-88389-z. PMC 8076212 Check |pmc= value (help). PMID 33903673.\n\n↑ Englund, A., Oliver, D., Chesney, E., Chester, L., Wilson, J., Sovi, S., De Micheli, A., Hodsoll, J., Fusar-Poli, P., Strang, J., Murray, R. M., Freeman, T. P., McGuire, P. (16 November 2022). \"Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios\". Neuropsychopharmacology: 1–8. doi:10.1038/s41386-022-01478-z. ISSN 1740-634X. Retrieved 25 November 2022.\n\n\n                    Context: \n                    This excerpt highlights recent research on how cannabidiol (CBD) can counteract the psychiatric side effects of THC, including findings from a 2019 ScienceDaily article and a 2022 neuropsychopharmacology study examining different CBD:THC ratios to improve cannabis safety. It provides scientific evidence supporting CBD's role in modulating THC's adverse effects, relevant to the document's overview of CBD's pharmacology, effects, and harm reduction potential. The references emphasize CBD’s potential to influence cannabis-related mental health outcomes.\n                "}
{"metadata": {"source": "erowid", "title": "Erowid LSD (Acid) Vault : FAQ", "description": "Frequently Asked Questions about LSD", "language": "No language found.", "url": "https://www.erowid.org/chemicals/lsd/lsd_faq.shtml", "drug": "LSD", "cid": 5761, "substance": "lsd", "category": "CHEMICALS", "erowid_column": "FAQ", "char_count": 70642, "word_count": 10952, "doc_id": "doc_156", "num_chunks": 103, "chunk_id": "156::chunk_60", "document_index": 156, "latency_s": 0.9880808000016259, "prompt_toks": 16429, "completion_toks": 72, "relevance_score": 4.4069402e-08}, "content": "Drug: LSD | cid: 5761\nSource: erowid | Source description: Frequently Asked Questions about LSD\nErowid name: lsd\nCategory: CHEMICALS\nField: FAQ\n\n                    Text: \n                    insight, during a year in psychotherapy he managed to give up alcohol and start a promising business. But his anxiety continued, and in order to allay it he had to keep himself very busy wheeling and dealing. Imitating his father, a successful self-made man who had married a woman twenty years younger than himself, PQ dated only women under the age of nineteen. Being attractive to young women was so imporant to him that much of his time was spent in the company of teenagers. During business hours he would wear a conservative three-piece suit and drive a new sedan, but when he was with his young friends he would wear a leather jacket and drive a motorcycle. Anxiety and fears of inadequacy dominated both of these lives. Several months after therapy began, during a weekend in a small resort town, his young friends decided to take LSD, and he felt obliged to dissemble his fears and join them; it was his first and only trip. He felt a panic he had never known before; he thought that he was\n\n\n                    Context: \n                    This excerpt describes a individual's psychological background and personal life, including ongoing anxiety and behaviors aiming to cope with it, leading to their first and only LSD experience during therapy. It highlights the emotional state, social context, and a subsequent panic reaction, providing insight into the mental health and trip dynamics discussed within the overall document on psychedelics and their psychological effects.\n                "}
